Variable | Early time window (n = 111) | Late time window (n = 131) | P values |
---|---|---|---|
Clinical baseline data | |||
Age, median (IQR), y | 71(60–79) | 68(56–75) | 0.036 |
Male, n (%) | 69(62.2) | 81(61.8) | 0.958 |
NIHSS score, median (IQR) | 17(14–21) | 15(11–19) | 0.008 |
ASPECTS, median (IQR) | 9(8–10) | 8(7–10) | 0.008 |
Risk factors | |||
Hypertension, n (%) | 77(69.4) | 84(64.1) | 0.389 |
Diabetes, n (%) | 22(19.8) | 21(16) | 0.442 |
Atrial fibrillation, n (%) | 62(55.9) | 43(32.8) | 0.001 |
Smoking, n (%) | 28(25.2) | 26(19.8) | 0.317 |
Baseline measurements | |||
SBP, median (IQR), mm Hg | 152(132–170) | 153(135–170) | 0.690 |
Platelet, mean (IQR), 109/L | 172(143–205) | 182(143–212) | 0.330 |
Glucose, median (IQR), mmol/L | 6.8(6.2–8.6) | 7.1(6.1–8.3) | 0.937 |
Occlusion site, n (%) | 0.249 | ||
ICA | 38(34.2) | 54(41.2) | |
MCA-M1 | 68(61.3) | 75(57.3) | |
MCA-M2 | 5(4.5) | 2(1.5) | |
Stroke cause, n (%) | 0.002 | ||
LAA | 32(29.1) | 66(51.6) | |
Cardioembolic | 60(54.5) | 47(36.7) | |
Others | 18(16.4) | 15(11.7) | |
Procedural data | |||
Intravenous thrombolysis, n (%) | 65(58.6) | 34(26) | 0.001 |
OTP, median (IQR), min | 240(167–293) | 590(457–836) | 0.001 |
OTR, median (IQR), min | 299(227–370) | 647(529–909) | 0.001 |
eTICI, 2b or 3, n (%) | 107(96.4) | 119(90.8) | 0.083 |
Outcome | |||
mRS score 0–2 (%) | 56(50.5) | 55(42) | 0.188 |
mRS score 6 (%) | 20(18) | 13(9.9) | 0.067 |
ICH (%) | 29(26.1) | 27(20.6) | 0.311 |